Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Strabismus Global Clinical Trials Review, H1

Strabismus Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Strabismus Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Strabismus Global Clinical Trials Review, H1, 2015" provides an overview of Strabismus clinical trials scenario. This report provides top line data relating to the clinical trials on Strabismus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Strabismus 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Strabismus to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Strabismus to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Strabismus Therapeutics Clinical Trials 28

Prominent Drugs 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Actavis plc 30

Clinical Trial Overview of Actavis plc 30

Herantis Pharma plc. 31

Clinical Trial Overview of Herantis Pharma plc. 31

GlaxoSmithKline Plc 32

Clinical Trial Overview of GlaxoSmithKline Plc 32

Clinical Trial Overview of Top Institutes / Government 33

Islamic Azad University of Tabriz 33

Clinical Trial Overview of Islamic Azad University of Tabriz 33

Jyotirmay eye clinic 34

Clinical Trial Overview of Jyotirmay eye clinic 34

Tehran University of Medical Sciences 35

Clinical Trial Overview of Tehran University of Medical Sciences 35

Central South University 36

Clinical Trial Overview of Central South University 36

Department of Health, South Africa 37

Clinical Trial Overview of Department of Health, South Africa 37

General Hospital Sveti Duh 38

Clinical Trial Overview of General Hospital Sveti Duh 38

Het Oogziekenhuis Rotterdam 39

Clinical Trial Overview of Het Oogziekenhuis Rotterdam 39

Hospital Universitario Ramon y Cajal 40

Clinical Trial Overview of Hospital Universitario Ramon y Cajal 40

Isfahan University of Medical Sciences 41

Clinical Trial Overview of Isfahan University of Medical Sciences 41

Jaeb Center for Health Research 42

Clinical Trial Overview of Jaeb Center for Health Research 42

Five Key Clinical Profiles 43

Appendix 59

Abbreviations 59

Definitions 59

Research Methodology 60

Secondary Research 60

About GlobalData 61

Contact Us 61

Disclaimer 61

Source 61

List of Figures

Strabismus Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Strabismus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Strabismus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Strabismus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Strabismus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Strabismus Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Strabismus to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Strabismus Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Strabismus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Strabismus to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Strabismus Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Strabismus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Strabismus Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Strabismus Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Strabismus Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Strabismus Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Strabismus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Strabismus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Strabismus Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Strabismus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Strabismus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

GlobalData Methodology 60

List of Tables

Strabismus Therapeutics, Global, Clinical Trials by Region, 2015* 7

Strabismus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Strabismus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Strabismus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Strabismus Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Strabismus Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Strabismus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Strabismus Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Strabismus to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Strabismus Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Strabismus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Strabismus to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Strabismus Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Strabismus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Strabismus Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Strabismus Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Strabismus Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Strabismus Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Strabismus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Strabismus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Strabismus Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Strabismus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Strabismus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 30

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Herantis Pharma plc., 2015* 31

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 32

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2015* 33

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Jyotirmay eye clinic, 2015* 34

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 35

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Central South University, 2015* 36

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 37

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by General Hospital Sveti Duh, 2015* 38

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Het Oogziekenhuis Rotterdam, 2015* 39

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Ramon y Cajal, 2015* 40

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 41

Strabismus Therapeutics Clinical Trials Market, Global, Clinical Trials by Jaeb Center for Health Research, 2015* 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Actavis plc

Herantis Pharma plc

GlaxoSmithKline Plc

Strabismus Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Strabismus, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com